{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:14:19Z","timestamp":1777583659650,"version":"3.51.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Tunneled pleural catheters (TPCs) generate an inflammatory reaction, which, along with frequent drainage, aids in achieving pleurodesis enabling removal in 30% to 50% of patients. However, it is unknown whether the technique of TPC placement influences pleurodesis outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective, single-center study of patients who underwent TPC placement from 2010 through 2018. Pleurodesis success was defined as TPC removal within 90 days of placement in the setting of no further drainage and in the absence of catheter malfunction, infection, patient\u2019s choice for another treatment modality, or other catheter-related complications. Pleurodesis failure was defined as patients who did not have TPC removal within 90 days of insertion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 326 patients underwent TPC insertion by thoracic surgery, interventional pulmonology, or interventional radiology. Fourteen patients were excluded due to insufficient follow-up. Of the 312 patients included in the final analysis, 32.7% achieved pleurodesis. Patients who had their TPC inserted thoracoscopically achieved higher pleurodesis success compared with a percutaneous technique (61.2% vs 24.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Thoracoscopically placed catheters had two times greater chance of removal than those inserted percutaneously (hazard ratio: 2.04, 95% CI: 1.14-3.64, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02) after controlling for pleural biopsies and sclerosing agents used during thoracoscopy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Thoracoscopic TPC placements may be associated with higher pleurodesis rates compared with a percutaneous technique. Our results are only hypothesis-generating, and these findings warrant confirmation in prospective studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/lbr.0000000000001007","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:02:04Z","timestamp":1741327324000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The Impact of Video-assisted Thoracoscopic Versus Percutaneous Tunneled Pleural Catheter Techniques on Pleurodesis Outcomes"],"prefix":"10.1097","volume":"32","author":[{"given":"Julie","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udit","family":"Chaddha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Urrutia-Royo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Hospital de Matar\u00f3, Consorci Sanitari del Maresme, Matar\u00f3"},{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona (UAB), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakul","family":"Ravikumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Pulmonary, Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivasubramanium V.","family":"Bhavani","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Thoracic Surgery, The University of Chicago Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Katsis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Critical Care Medicine, Rush University Medical Center, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark K.","family":"Ferguson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Septimiu","family":"Murgu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Pulmonary, Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4]]},"reference":[{"key":"R1-20250307","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An Official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20250307","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ejcts\/ezy258","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"55","author":"Bibby","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"R3-20250307","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R4-20250307","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"R5-20250307","first-page":"697","article-title":"A simple solution for complicated pleural effusions","volume":"1","author":"Murthy","year":"2006","journal-title":"J Thorac Oncol"},{"key":"R6-20250307","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/LBR.0000000000000602","article-title":"Pleural fluid cytokine levels at baseline and over time are associated with time to IPC removal: an exploratory study","volume":"27","author":"Grosu","year":"2020","journal-title":"J Bronchol Interv Pulmonol"},{"key":"R7-20250307","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler","year":"2005","journal-title":"Chest"},{"key":"R8-20250307","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"key":"R9-20250307","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20250307","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/JTO.0b013e31820d614f","article-title":"Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters","volume":"6","author":"Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R11-20250307","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2008-1039109","article-title":"Recurrent pleural effusion: who benefits from a tunneled pleural catheter?","volume":"57","author":"Schneider","year":"2009","journal-title":"Thorac Cardiovasc Surg"},{"key":"R12-20250307","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.2015.16840","article-title":"Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial","volume":"314","author":"Rahman","year":"2015","journal-title":"JAMA"},{"key":"R13-20250307","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial","volume":"323","author":"Bhatnagar","year":"2020","journal-title":"JAMA"},{"key":"R14-20250307","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/resp.13937","article-title":"Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal","volume":"26","author":"Chaddha","year":"2020","journal-title":"Respirology"},{"key":"R15-20250307","doi-asserted-by":"crossref","first-page":"e3996","DOI":"10.1097\/MD.0000000000003996","article-title":"Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion","volume":"95","author":"Verma","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R16-20250307","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1378\/chest.117.1.87","article-title":"Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data","volume":"117","author":"Heffner","year":"2000","journal-title":"Chest"},{"key":"R17-20250307","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13063-022-06405-7","article-title":"Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (\u00b1talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion","volume":"23","author":"Fitzgerald","year":"2022","journal-title":"Trials"}],"container-title":["Journal of Bronchology &amp; Interventional Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000001007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:02:10Z","timestamp":1741327330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000001007"}},"subtitle":["A Retrospective, Single-center Study"],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/lbr.0000000000001007","relation":{},"ISSN":["1948-8270"],"issn-type":[{"value":"1948-8270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"2024-06-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}